Related Experiment Video
Updated: Jun 12, 2026
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Infectious Diseases Society of America (IDSA) Position Statement: Why IDSA Did Not Endorse the Community-Acquired
Michael Klompas1,2, Majdi Al-Hasan3,4, Mayar Al Mohajer5,6
1Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA.
Abstract:
The American Thoracic Society recently released updated community-acquired pneumonia (CAP) guidelines. The Infectious Diseases Society of America (IDSA) agreed with 8 of the 10 recommendations in the guidelines but declined to endorse the guidelines because they include recommendations for use of antibiotics in outpatients with comorbidities and inpatients with nonsevere CAP who test positive for respiratory viruses. It is noted in the guidelines that bacterial coinfections are common and that delaying antibiotics may be harmful. IDSA notes, however, that nondiscriminatory use of antibiotics for patients with CAP and positive viral assays confers more risks than benefits. Most patients do not have bacterial coinfections, and briefly withholding antibiotics for patients with nonsevere illness to clarify the diagnosis is safe. In this era of precision medicine, IDSA instead recommends individualized, dynamic decision-making that takes into account each patient´s evolving trajectory, severity of illness and balance of clinical features for and against coinfection.
Insights
The Infectious Diseases Society of America (IDSA) disagrees with new community-acquired pneumonia (CAP) guidelines on antibiotic use in viral respiratory infections. IDSA recommends personalized treatment over broad antibiotic administration for better patient outcomes.
Area of Science:
- Infectious Diseases
- Pulmonology
- Clinical Guidelines
Background:
- The American Thoracic Society (ATS) issued updated guidelines for community-acquired pneumonia (CAP).
- The Infectious Diseases Society of America (IDSA) partially agreed but withheld endorsement due to specific recommendations.
- Disagreement centers on antibiotic use in patients with CAP and positive respiratory viral assays, especially those with comorbidities or non-severe illness.
Purpose of the Study:
- To outline the IDSA's position on the updated ATS CAP guidelines.
- To explain the rationale behind IDSA's decision not to endorse the guidelines.
- To advocate for an individualized approach to antibiotic decision-making in CAP management.
Main Methods:
- Review and comparison of the ATS CAP guidelines with existing IDSA principles.
- Analysis of the risks and benefits of antibiotic use in CAP patients with viral coinfections.
- Consideration of patient factors including comorbidities, illness severity, and clinical trajectory.
Main Results:
- IDSA supports 8 out of 10 ATS recommendations.
- IDSA opposes routine antibiotic use in CAP patients with positive viral tests, citing risks outweighing benefits.
- IDSA asserts that withholding antibiotics temporarily in non-severe cases is safe and aids diagnosis.
Conclusions:
- IDSA recommends against indiscriminate antibiotic use in CAP patients with viral respiratory infections.
- IDSA advocates for precision medicine principles, emphasizing individualized, dynamic treatment decisions.
- Management should consider the patient's evolving condition, illness severity, and likelihood of bacterial coinfection.
Related Concept Videos
01:22Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:29Respiratory Syncytial Virus Disease
01:29Pneumonia I: Introduction